![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1332004 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PGP mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PGP mRNA | CTD | PMID:21215274, PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PGP mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1332004 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PGP mRNA | CTD | PMID:21570461 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1332004 | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of PGP mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1351096 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of PGP protein | CTD | PMID:34186270 | 4-nitrophenyl phosphate | decreases phosphorylation | ISO | RGD:1332004 | 6480464 | PGP protein results in decreased phosphorylation of nitrophenylphosphate analog | CTD | PMID:24338473 | acrylamide | decreases expression | ISO | RGD:1351096 | 6480464 | Acrylamide results in decreased expression of PGP mRNA | CTD | PMID:32763439 | ADP | decreases phosphorylation | ISO | RGD:1332004 | 6480464 | PGP protein results in decreased phosphorylation of Adenosine Diphosphate | CTD | PMID:24338473 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of PGP mRNA | CTD | PMID:30779732 | arsane | affects methylation | ISO | RGD:1351096 | 6480464 | Arsenic affects the methylation of PGP gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1351096 | 6480464 | Arsenic affects the methylation of PGP gene | CTD | PMID:25304211 | ATP | decreases phosphorylation | ISO | RGD:1332004 | 6480464 | PGP protein results in decreased phosphorylation of Adenosine Triphosphate | CTD | PMID:24338473 | benzalkonium chloride | increases expression | ISO | RGD:1332004 | 6480464 | Benzalkonium Compounds results in increased expression of PGP mRNA | CTD | PMID:31199489 | benzo[a]pyrene | decreases expression | ISO | RGD:1332004 | 6480464 | Benzo(a)pyrene results in decreased expression of PGP mRNA | CTD | PMID:27195522 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PGP mRNA | CTD | PMID:34947998 | bisphenol A | increases expression | ISO | RGD:1332004 | 6480464 | bisphenol A results in increased expression of PGP mRNA | CTD | PMID:32156529 | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of PGP protein | CTD | PMID:28903499 | calcium atom | decreases activity | ISO | RGD:1332004 | 6480464 | Calcium results in decreased activity of PGP protein | CTD | PMID:24338473 | calcium(0) | decreases activity | ISO | RGD:1332004 | 6480464 | Calcium results in decreased activity of PGP protein | CTD | PMID:24338473 | cisplatin | multiple interactions | ISO | RGD:1351096 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of PGP mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | RGD:1351096 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of PGP mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1351096 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of PGP mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | RGD:1351096 | 6480464 | Copper Sulfate results in decreased expression of PGP mRNA | CTD | PMID:19549813 | dextran sulfate | increases expression | ISO | RGD:1332004 | 6480464 | Dextran Sulfate results in increased expression of PGP mRNA | CTD | PMID:35093514 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of PGP mRNA | CTD | PMID:21266533 | dibutyl phthalate | decreases expression | ISO | RGD:1332004 | 6480464 | Dibutyl Phthalate results in decreased expression of PGP mRNA | CTD | PMID:21266533 | dioxygen | increases expression | ISO | RGD:1332004 | 6480464 | Oxygen deficiency results in increased expression of PGP mRNA | CTD | PMID:20880076, PMID:24205000 | dioxygen | multiple interactions | ISO | RGD:1332004 | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of PGP mRNA | CTD | PMID:30529165 | dioxygen | decreases expression | ISO | RGD:1351096 | 6480464 | Oxygen deficiency results in decreased expression of PGP mRNA | CTD | PMID:26516004 | dioxygen | affects methylation | ISO | RGD:1332004 | 6480464 | Oxygen deficiency affects the methylation of PGP promoter | CTD | PMID:24205000 | doxorubicin | decreases expression | ISO | RGD:1351096 | 6480464 | Doxorubicin results in decreased expression of PGP mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of PGP mRNA | CTD | PMID:29391264 | enzyme inhibitor | multiple interactions | ISO | RGD:1351096 | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PGP protein | CTD | PMID:23301498 | ethyl methanesulfonate | decreases expression | ISO | RGD:1351096 | 6480464 | Ethyl Methanesulfonate results in decreased expression of PGP mRNA | CTD | PMID:23649840 | ethylenediaminetetraacetic acid | decreases activity | ISO | RGD:1332004 | 6480464 | Edetic Acid results in decreased activity of PGP protein | CTD | PMID:24338473 | fluoranthene | multiple interactions | ISO | RGD:1332004 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PGP mRNA | CTD | PMID:28329830 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of PGP mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:1332004 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PGP mRNA | CTD | PMID:22206623 | formaldehyde | decreases expression | ISO | RGD:1351096 | 6480464 | Formaldehyde results in decreased expression of PGP mRNA | CTD | PMID:23649840 | GDP | decreases phosphorylation | ISO | RGD:1332004 | 6480464 | PGP protein results in decreased phosphorylation of Guanosine Diphosphate | CTD | PMID:24338473 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of PGP mRNA | CTD | PMID:33387578 | GTP | decreases phosphorylation | ISO | RGD:1332004 | 6480464 | PGP protein results in decreased phosphorylation of Guanosine Triphosphate | CTD | PMID:24338473 | inulin | multiple interactions | ISO | RGD:1332004 | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PGP mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | ISO | RGD:1351096 | 6480464 | Ivermectin results in decreased expression of PGP protein | CTD | PMID:32959892 | lipopolysaccharide | multiple interactions | ISO | RGD:1351096 | 6480464 | [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of PGP mRNA | CTD | PMID:26667767 | methyl methanesulfonate | decreases expression | ISO | RGD:1351096 | 6480464 | Methyl Methanesulfonate results in decreased expression of PGP mRNA | CTD | PMID:23649840 | miconazole | increases expression | ISO | RGD:1332004 | 6480464 | Miconazole results in increased expression of PGP mRNA | CTD | PMID:27462272 | paracetamol | affects expression | ISO | RGD:1332004 | 6480464 | Acetaminophen affects the expression of PGP mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PGP mRNA | CTD | PMID:33387578 | pentachlorophenol | increases expression | ISO | RGD:1332004 | 6480464 | Pentachlorophenol results in increased expression of PGP mRNA | CTD | PMID:23892564 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1332004 | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PGP mRNA | CTD | PMID:36331819 | resveratrol | multiple interactions | ISO | RGD:1351096 | 6480464 | [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of PGP mRNA, [Plant Extracts co-treated with Resveratrol] results in increased expression of PGP mRNA | CTD | PMID:23557933, PMID:26667767 | sodium arsenite | increases expression | ISO | RGD:1351096 | 6480464 | sodium arsenite results in increased expression of PGP mRNA | CTD | PMID:34032870 | sulforaphane | multiple interactions | ISO | RGD:1332004 | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of PGP mRNA | CTD | PMID:30529165 | sunitinib | decreases expression | ISO | RGD:1351096 | 6480464 | Sunitinib results in decreased expression of PGP mRNA | CTD | PMID:31533062 | tetrachloroethene | decreases expression | ISO | RGD:1332004 | 6480464 | Tetrachloroethylene results in decreased expression of PGP mRNA | CTD | PMID:28973375 | tetrachloromethane | increases expression | ISO | RGD:1332004 | 6480464 | Carbon Tetrachloride results in increased expression of PGP mRNA | CTD | PMID:31919559 | trifluoroberyllate(1-) | decreases activity | ISO | RGD:1332004 | 6480464 | beryllium trifluoride results in decreased activity of PGP protein | CTD | PMID:24338473 | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of PGP mRNA | CTD | PMID:30589522 | valproic acid | increases expression | ISO | RGD:1351096 | 6480464 | Valproic Acid results in increased expression of PGP mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | RGD:1351096 | 6480464 | Valproic Acid affects the expression of PGP mRNA | CTD | PMID:25979313 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of PGP mRNA | CTD | PMID:23555832 | vincristine | decreases expression | ISO | RGD:1351096 | 6480464 | Vincristine results in decreased expression of PGP mRNA | CTD | PMID:23649840 | |